Please login to the form below

Not currently logged in

Pharmaceutical Market Europe - February 2013

This issue PME talks to …

Steven Bates

The BioIndustry Association CEO talks about the state of UK biotech, its shared ecosystem with the country's pharmaceutical industry and the funding challenges biotech faces 

And we take a look at …

Orphan diseases

Orphan diseases represent one of the most exciting and emotive areas in modern medicine and need a communications strategy that covers a spectrum of issues, say Dr Jonathan Morton and Dr Richard White of OxfordPharmagenesis

South Korea: the ascendance of biobetters

Global pharma companies need to take the capabilities and experience of South Korean firms into consideration when developing their competitive strategies

Masterclass: channel strategy

Channel strategy could be a significant stone unturned in the battle to win customers and patients, says David Watson of a MSI Consultancy

Innovation: what to look out for in 2013

Context-based services and social media are among the major technology trends that pharma will need to embrace in the year ahead

Pipeline: promising treatments for melanoma

The BREAK-2 phase II trial showed that dabrafenib 150mg twice daily had rapid onset of action, high response rates and prolonged progression-free survival 

View PME February 2013 online

Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.

PME is also available to download as an app for iPhone and iPad

Featured jobs

Subscribe to our email news alerts


Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...